#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Herpes simplex Lip and/or oral cavity cancer Amyotrophic lateral sclerosis Small cell lung cancer extensive stage Breast angiosarcoma metastatic Follicle centre lymphoma follicular grade I II – III refractory Acute respiratory distress syndrome Prodromal Alzheimer's disease Chronic graft versus host disease Neonatal asphyxia Interstitial lung disease Vascular calcification CDKL5 deficiency disorder Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Glomerulonephritis membranous More trials…

    Learn about Rare Diseases

    Urea cycle disorder Mantle cell lymphoma refractory – Diagnostics Familial haemophagocytic lymphohistiocytosis – Basic Information Uterine leiomyosarcoma – Basic Information Krabbe’s disease – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Hepatoblastoma – Diagnostics Antisynthetase syndrome Osteosarcoma recurrent – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Saruparib Ds-3939A Ale.c04 VTX-002 Paraffin White Soft Rly-4008 Cx-037231 Ly3541860 Efavirenz Tominersen Ucart20X22 Dacarbazine Hypromellose C1 Esterase Inhibitor (Human) Hydrochlorothiazide Sotalol Iptacopan Hydrochloride Gs-1427 Ambroxol Hydrochloride Abc-23A-116 More therapies…

    Learn about Your Condition

    Pancreatic carcinoma Gastrointestinal carcinoma Malignant peritoneal neoplasm Congenital myopathy Allergic respiratory disease Craniosynostosis Systemic infection Post procedural swelling Rectal cancer stage III Phenylketonuria Basal cell carcinoma Primary hyperthyroidism Ichthyosis Carpal tunnel syndrome Primary biliary cholangitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Eculizumab in Adults with Hypertensive Emergency-Related Hemolytic Uremic Syndrome Requiring Dialysis or with Severe Kidney Problems

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Eculizumab
    France

  • Study on Trastuzumab, Pertuzumab, and Tucatinib for Patients with Stage II-III HER2-Positive Breast Cancer Without Chemotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    • Tucatinib
    The Netherlands

  • Study on Pre-Surgery Immunotherapy with Relatlimab, Anti-IL-8 mAb, and Ipilimumab for Early-Stage Colon Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Anti-Il-8 Human Monoclonal Antibody
    • Celecoxib
    • Ipilimumab
    The Netherlands

  • Study on the Safety and Effectiveness of Repotrectinib for Patients with ROS1-Positive Non-Small Cell Lung Cancer and Active Brain Metastasis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Non-small cell lung cancer
    Investigated Drugs:
    • Repotrectinib
    Austria Germany Spain

  • Study on Human Plasma Protein vs. Crystalloid for Fluid Management in Children with Scoliosis Undergoing Spinal Fusion Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuromuscular scoliosis
    Investigated Drugs:
    • Human Plasma Protein
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Finland

  • Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Topotecan
    • Dostarlimab
    • Niraparib
    Czechia France Germany Italy
Previous Page
1 … 415 416 417 418 419 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!